| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381424C Biaryl sulfonamides and methods for using same |
| 04/15/2008 | US7358268 Imidazole derivatives as factor Xa inhibitors |
| 04/15/2008 | CA2410303C Beta-amino acid nitrile derivatives |
| 04/10/2008 | US20080085912 5-(optionally substituted)-3-carboxy-isoxazoles such as 5-methylisoxazole-3-carboxylic acid; treating immune-mediated diseases, cancer, transplant rejection, psoriasis; Janus kinase inhibitors |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/09/2008 | CN101160293A Azole derivatives in the form of lipase and phospholipase inhibitors |
| 04/03/2008 | WO2008039645A1 Compounds which modulate the cb2 receptor |
| 04/03/2008 | WO2008014199A3 Sulfonyl compounds which modulate the cb2 receptor |
| 04/03/2008 | US20080081914 Claimed lithium or amine salt; for zonisamide production |
| 04/03/2008 | US20080081822 N-(5-tert-Butyl-isoxazol-3-yl)-2-cyclohexanesulfonyl-2-methyl-propionamide; cannabinoid receptor agonist, antagonist; analgesic, antiinflammatory and antitumor agent; neuropatic pain |
| 04/03/2008 | CA2664310A1 Compounds which modulate the cb2 receptor |
| 04/01/2008 | US7351825 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) (MMP) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 03/27/2008 | WO2008036653A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | WO2008036642A2 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | US20080076767 Controlling cell proliferation, cell differentiation,autoimmune disease; N-[4-(3-amino-1,2-benzisoxazol-4-yl)phenyl]-N'-(3-methylphenyl)urea; 2-[4-(3-amino-1H-indazol-4-yl)phenyl]-N-(3-chlorophenyl)acetamide; N-[4-(3-amino-1,2-benzisothiazol-4-yl)phenyl]-N'-(3,5-dimethylphenyl)urea; anticarcinogenic |
| 03/27/2008 | CA2664247A1 Inhibitors of phosphodiesterase type-iv |
| 03/27/2008 | CA2663057A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/27/2008 | CA2662773A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 03/26/2008 | EP1902038A2 Method for producing 3-arylmethylthio- and 3-heteroarylmethylthio-4,5-dihydro-isoxazoline derivatives |
| 03/26/2008 | EP1901731A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 03/26/2008 | EP1556342B1 Phenethanolamine derivative for the treatment of respiratory diseases |
| 03/25/2008 | US7348440 Mitotic kinesin inhibitors |
| 03/25/2008 | US7348359 Retinoid X receptor modulators |
| 03/25/2008 | US7348342 5-(4-Fluorophenyl)-1-(4-methylsulfoximinylphenyl)-3-trifluoromethyl-1H-pyrazole; prostaglandin and cyclooxygenase inhibitor; antiinflammatory, analgesic, and antipyretic agent |
| 03/25/2008 | US7348322 6-{2-Hydroxyimino-3-[1-(2-trifluoromethyl-phenyl)-cyclobutyl]-propylamino}-4-methyl-benzo[d][1,2]oxazin-1-one; antiallergic, asthma, artritis, graft versus host disease; side effect reduction; GR/ligand complex represses transcription of pro-inflammatory genes by directly interacting with NF-kB or AP-1 |
| 03/20/2008 | WO2008016692A3 Chemical compounds |
| 03/20/2008 | US20080070961 storage stability; precipitation |
| 03/20/2008 | US20080070960 Novel 3-Aryl-1,2-Benzisoxazole Derivatives and Use Thereof as Medicinal Products Against Cancer |
| 03/20/2008 | US20080070959 Guanylhydrazone compounds, compositions, methods of making and using |
| 03/20/2008 | US20080070937 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 03/20/2008 | US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators |
| 03/19/2008 | CN101146780A New 3-aryl-1,2-benzisoxazole compounds are heat shock protein 90 inhibitors, useful to treat solid or liquid cancer, preferably cancers resistant to cytotoxic agents |
| 03/18/2008 | US7345094 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 03/18/2008 | CA2277893C 4-(3-heterocyclyl-1-benzoyl)pyrazoles and their use as herbicides |
| 03/13/2008 | WO2008030618A1 Benzo-fused compounds for use in treating metabolic disorders |
| 03/13/2008 | WO2008030520A1 Heterocyclic gpr40 modulators |
| 03/13/2008 | US20080064748 Substituted enaminones, their derivatives and uses thereof |
| 03/13/2008 | US20080064731 Remedy for chronic disease |
| 03/12/2008 | EP1896394A1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/12/2008 | CN101142198A Isoxazole combretastatin derivatives for the treatment of proliferative disorders |
| 03/12/2008 | CN101142172A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/11/2008 | US7342036 Isoxazole derivatives and process for producing the same |
| 03/11/2008 | CA2293382C Piperazine derivatives and their use as anti-inflammatory agents |
| 03/06/2008 | WO2008026217A1 Improved and simplified process for the preparation of 1,2-benzisoxazole-3-acetic acid |
| 03/06/2008 | WO2008025694A1 Inhibitors for glyt-1 |
| 03/06/2008 | WO2008011110A3 Di-amino-substituted heterocyclic compounds and methods of use |
| 03/06/2008 | WO2007145835A3 Benzamide derivatives as modulators of 11beta-hsd1 for treating diabetes and obesity |
| 03/06/2008 | US20080058530 Isoxazole derivatives and process for producing the same |
| 03/06/2008 | US20080058515 indazolylacrylamide derivatives are useful in the treatment of diseases associated with inappropriate SGK-1 activity |
| 03/06/2008 | US20080058340 MEK kinase (mitogen-activated ERK-activating kinases or MAP kinase kinase); cancer, tumors, infections, autoimmune disorders, stroke, ischemia, rheumatoid arthritis, multiple sclerosis, psoriasis, restenosis; 1-sulfonamido-2-(phenylamino)-4-fluorobenzene compounds |
| 03/06/2008 | US20080058336 Secretase inhibitor |
| 03/06/2008 | US20080058331 Inhibitors for GlyT-1 |
| 03/06/2008 | US20080058314 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/06/2008 | CA2661863A1 Inhibitors for glyt-1 |
| 03/05/2008 | EP1894919A1 Heterocyclic compound having type i 11 beta hydroxysteroid dehydrogenase inhibitory activity |
| 03/05/2008 | EP1893591A1 POLYCYCLIC OXADIAZOLES OR I SOXAZOLES AND THEIR USE AS SlP RECEPTOR LIGANDS |
| 03/05/2008 | EP1893589A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 03/05/2008 | CN101137616A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 03/05/2008 | CN101137412A Substituted biaryl compounds as factor xia inhibitors |
| 03/04/2008 | US7338969 Acyclic, aromatic, heteroaromatic and cyclic ring containing amido-derivatives, useful as antibacterial agent; inhibition of formation of biofilms in personal hygiene articles, toileteries, cosmetics and in industrial settings like ship hulls, food processing systems, oil recovery or paper making plants |
| 02/28/2008 | WO2008023157A1 Nitrogen containing heterocyclic compounds useful as m3-receptor modulators |
| 02/28/2008 | WO2008022938A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | US20080051441 Aryl Sulphonamide Modulators |
| 02/28/2008 | US20080051287 Isoxazoline Derivatives and Their Use as Herbicides |
| 02/28/2008 | CA2661459A1 Di-aromatic substituted amides as inhibitors for glyt1 |
| 02/28/2008 | CA2661166A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 02/27/2008 | EP1891026A2 Cycloalkylidene compounds as selective estrogen receptor modulators |
| 02/27/2008 | EP1399423B9 Anthranilic acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds |
| 02/27/2008 | EP1248612B1 Novel compounds and compositions as protease inhibitors |
| 02/27/2008 | EP1150959B1 Solid-state form of celecoxib having enhanced bioavailability |
| 02/26/2008 | US7335753 Bifunctional heterocyclic compounds and methods of making and using same |
| 02/26/2008 | US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide |
| 02/26/2008 | US7335666 That inhibit serotonin reuptake and are antagonists of the 5HT1A receptor; 2-[3-(6-Fluoro-indol-1-ylmethyl)-azetidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline for example |
| 02/26/2008 | CA2322195C Novel diphenyl-substituted 5-ring-heterocycles, method for producing them and their use as medicaments |
| 02/21/2008 | WO2008020007A2 Process for the preparation of 5-hydroxyisoxazolidines, 5-isoxazolidinones, b-amino acids, b-amino aldehydes and derivatives thereof |
| 02/21/2008 | US20080045580 Novel Isoxazole Compounds Having Ppar Agonist Activity |
| 02/21/2008 | US20080045546 Tetradydro-Naphthalene And Urea Derivatives |
| 02/21/2008 | US20080045492 Mitotic Kinesin Inhibitors |
| 02/21/2008 | US20080045480 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 02/21/2008 | US20080044401 Drug therapy for celiac sprue |
| 02/20/2008 | EP1889845A1 Novel pleuromutilin derivatives |
| 02/20/2008 | EP1889840A1 Rearrangement of spirolactams |
| 02/20/2008 | EP1888542A1 Substituted spiro-compounds and the use thereof for producing medicaments |
| 02/20/2008 | EP1888541A1 Benzo(d)isoxazol-3-yl-amine compounds and their use as vanilloid receptor ligands |
| 02/20/2008 | CN101128441A Fused aromatic compounds having anti-diabetic activity |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332514 Dibenzylamine compound and medicinal use thereof |
| 02/19/2008 | CA2226582C Non-allosteric gabaa agonists for treating sleep disorders |
| 02/14/2008 | US20080039629 Benzothniazole compositions and their use as ubiquition ligation inhibitors |
| 02/14/2008 | US20080039514 anticholesterol agents; 2-Methyl-2-{3-[3-(4-trifluoromethyl-phenyl)-benzo[d]isoxazol-6-yloxy]-phenoxy}-propionic acid; associated with atherosclerosis and non-insulin dependent diabetes |
| 02/14/2008 | US20080039513 Marine Compounds with Calcium Channel Blocking Properties for the Treatment of Cognitive or Neurodegenerative Diseases |
| 02/14/2008 | US20080039464 Compounds Which Modulate The CB2 Receptor |
| 02/14/2008 | US20080039438 1B-Methylcarbapenem Derivative and Process for the Preparation Thereof |
| 02/14/2008 | US20080039327 3-heterocyclyl-substituted benzoyl derivatives |
| 02/13/2008 | EP1887000A1 Arylacetate derivative having isoxazole skeleton |
| 02/13/2008 | CN101124201A Parp抑制剂 Parp inhibitors |
| 02/13/2008 | CN101124199A 5-substituted-2-phenylamino-benzamide as MEK inhibitor |
| 02/12/2008 | CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them |